We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOC icon
251
Sable Offshore Corp
SOC
$859M
$324K 0.01%
35,956
+16,261
+83% +$154K
MEDP icon
252
Medpace
MEDP
$16.1B
$310K 0.01%
552
-52
-9% -$29.5K
ORCL icon
253
Oracle
ORCL
$367B
$307K 0.01%
+1,573
New +$375K
RVMD icon
254
Revolution Medicines
RVMD
$40.9B
$303K 0.01%
3,798
-224
-6% -$14.7K
SOLV icon
255
Solventum
SOLV
$15B
$299K 0.01%
3,768
-70
-2% -$5.36K
ROIV icon
256
Roivant Sciences
ROIV
$24.8B
$297K 0.01%
13,668
-1,024
-7% -$20.2K
BBIO icon
257
BridgeBio Pharma
BBIO
$16.1B
$290K ﹤0.01%
3,786
-327
-8% -$21.5K
ALGN icon
258
Align Technology
ALGN
$12.4B
$287K ﹤0.01%
1,839
-33
-2% -$4.73K
HD icon
259
Home Depot
HD
$332B
$283K ﹤0.01%
821
– –
ESS icon
260
Essex Property Trust
ESS
$18.1B
$279K ﹤0.01%
1,067
-6
-0.6% -$1.55K
NBIX icon
261
Neurocrine Biosciences
NBIX
$18.7B
$278K ﹤0.01%
1,958
-176
-8% -$25.5K
SHEL icon
262
Shell
SHEL
$250B
$270K ﹤0.01%
+3,672
New +$270K
MAA icon
263
Mid-America Apartment Communities
MAA
$15.5B
$269K ﹤0.01%
1,940
-25
-1% -$3.33K
INVH icon
264
Invitation Homes
INVH
$17.6B
$268K ﹤0.01%
9,649
-16
-0.2% -$447
BAX icon
265
Baxter International
BAX
$13.8B
$265K ﹤0.01%
13,881
-261
-2% -$5.22K
CRL icon
266
Charles River Laboratories
CRL
$11.3B
$264K ﹤0.01%
1,325
-23
-2% -$4.17K
REX icon
267
REX American Resources
REX
$1.44B
$263K ﹤0.01%
8,143
+205
+3% +$6.68K
GH icon
268
Guardant Health
GH
$20.2B
$260K ﹤0.01%
2,541
-142
-5% -$12.7K
MDGL icon
269
Madrigal Pharmaceuticals
MDGL
$11.4B
$259K ﹤0.01%
445
-35
-7% -$17.9K
ASND icon
270
Ascendis Pharma A/S
ASND
$16.5B
$257K ﹤0.01%
1,206
-103
-8% -$21.3K
SUI icon
271
Sun Communities
SUI
$15.3B
$257K ﹤0.01%
2,074
-63
-3% -$7.88K
SMMT icon
272
Summit Therapeutics
SMMT
$10.7B
$256K ﹤0.01%
14,629
-1,353
-8% -$25.5K
ACN icon
273
Accenture
ACN
$99.9B
$254K ﹤0.01%
947
– –
SNY icon
274
Sanofi
SNY
$103B
$252K ﹤0.01%
5,199
-574
-10% -$28.5K
IONS icon
275
Ionis Pharmaceuticals
IONS
$8.81B
$252K ﹤0.01%
3,183
-246
-7% -$18.5K
9 10
11
12 13

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.